The National Cancer Institute has quietly moved a familiar and polarizing drug into its preclinical pipeline: ivermectin, ...

Scientists have discovered why ovarian cancer spreads so rapidly through the abdomen. Cancer cells enlist normally protective abdominal cells, forming mixed groups that work together to invade new ...

A newly identified driver of melanoma growth not only promotes tumor blood supply but also helps tumors evade immune attack.

Researchers have identified a biological mechanism that helps explain why some lung and ovarian cancers become resistant to chemotherapy, offering insight into why cancers recur. The study, published ...

Ovarian cancer kills more women than any other gynecological cancer. Most patients receive their diagnosis only after the ...

A new research paper was published in Volume 13 of Oncoscience on January 28, 2026, titled "Dual targeting of oncogenic microtubules and mitochondria in PDAC." In this study led by first author ...

Overcoming tumor resistance to chemotherapy drugs has long been a challenge for oncology clinicians and researchers. Now, a new study suggests that blocking a key protein, p300, may force damaged ...

Moving gemcitabine/nab-paclitaxel to every-other-week dosing decreases infusion visits and may lessen cumulative toxicity, ...

New pancreatic cancer research shows tumours eliminated in preclinical studies. Experts explain what it means and when patients may benefit.